Lumbar Disc Herniation

Description of Current Clinical Studies

Lumbar Disc Herniation

A Study to Evaluate the Long Term Safety of a Medication Called SI-6603 for Patients with a Lumbar Disc Herniation

CATEGORY: 
Chronic Pain for patients with lumbar disc herniation (a rupture or protrusion of the disc between the bones of the spine)

PURPOSE: 
The purpose of this study is to evaluate how well the drug works and long-term safety of a medication called SI-6603 in patients with a lumbar disc herniation by monitoring the patients for 1 year after the administration of a single dose of the medication.

Patients will receive either an injection of the study drug into the herniated disc or a placebo (a product that has no active part)

Information regarding safety and side effects that may occur will also be collected.

METHOD OF ADMINISTRATION: 
Single injection of study medication

Do you get nervous or anxious prior to a medical procedure? Our affiliated practices now offer Nitrous Gas Analgesia (Pronox) for select treatments! Click the video below to learn more.

INVESTIGATOR: 
Cherian Sajan, MD

KEY REQUIREMENTS TO QUALIFY FOR THIS STUDY:

• Must be between 30 and 70 years of age
• Must have been diagnosed with lumbar disc herniation
• Must have pain in only one leg:
• Must have received 6 weeks or more of adequate conservative medication treatment without any improvement of your pain?

LENGTH/DURATION: 
Each subject will be asked to visit the clinic on 10 to 11 days over the period of a year. Most visits will take approximately 1 to 3 hours, but the visit when you receive the experimental study treatment may take a full day.

LOCATION: 
1693 Lee Road Winter Park, Fl. 32789 

COMPENSATION: 
Qualified participants may receive up to $500 for time and travel

WHOM TO CONTACT: 
Recruitment Department: 407-203-7936